Nervgen Pharma Corp (NGEN.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 7,532 | 6,404 | 6,171 | 6,469 | 6,035 |
| Operating Income | -7,532 | -6,404 | -6,171 | -6,469 | -6,035 |
| Other Income | 5,856 | -20,505 | 2,015 | -2,635 | 2,087 |
| Pre-tax Income | -1,676 | -26,909 | -4,156 | -9,104 | -3,948 |
| Net Income Continuous | -1,676 | -26,909 | -4,156 | -9,104 | -3,948 |
| Net Income | $-1,676 | $-26,909 | $-4,156 | $-9,104 | $-3,948 |
| EPS Basic Total Ops | N/A | N/A | -0.06 | -0.13 | -0.06 |
| EPS Basic Continuous Ops | N/A | N/A | -0.06 | -0.13 | -0.06 |
| EPS Diluted Total Ops | N/A | N/A | -0.06 | -0.13 | -0.06 |
| EPS Diluted Continuous Ops | N/A | N/A | -0.06 | -0.13 | -0.06 |
| EBITDA(a) | $-7,532 | $-6,390 | $-6,157 | $-6,455 | $-6,021 |